Earlier this year, the company also reported phase 1b data with APG808, a long-acting IL-4-targeting antibody for asthma and other type 2 allergic diseases.

All 36 teams will enter the league phase of the 2025/26 UEFA Conference League via qualifying, with none qualifying directly. There is a first, second and third qualifying round, then the play-offs.